JPMorgan Chase & Co. Chief Financial Officer Jeremy Barnum completed an open-market sale of company stock. On May 5, 2026, he sold 3,022 shares of Common Stock at an average price of $309.4082 per share. After this transaction, he directly holds 32,438 shares of JPMorgan Chase & Co. common stock.
JPMorgan Chase & Co. Chief Risk Officer Ashley Bacon completed an open-market sale of 4,070 shares of JPM common stock on May 5, 2026 at $309.4242 per share. Following this transaction, she directly owns 248,785 shares of JPMorgan Chase & Co. common stock.
JPMorgan Chase & Co.'s Chief Operating Officer Jennifer Piepszak reported an open-market sale of 4,919 shares of common stock. The shares were sold at a price of $309.4201 per share. After this transaction, she directly holds 85,082 shares of JPMorgan Chase & Co. common stock.
Jeremy Barnum submitted a Form 144 disclosing the sale of 5,611 shares of Common Stock on 04/15/2026 for $1,720,064.57. The filing lists equity compensation grants acquired on 01/13/2023 (2,846 shares) and 01/13/2026 (176 shares) as the source.
Insider transaction filing for JPMorgan Chase common stock showing planned and recent sales. The filing lists 4,070 shares of Common Stock (par value $1) identified as "Securities To Be Sold" and acquired on 03/25/2024. It also reports 7,558 shares sold on 04/15/2026, producing proceeds of $2,316,931.46. The filing lists J.P. Morgan Securities LLC as the broker and includes a filing date of 05/05/2026.
JPMorgan Chase & Co. submitted a Rule 144 notice regarding common stock acquired as equity compensation.
The filer lists 4,919 shares of Common Stock with an associated figure of $1,522,037.48 and states these shares were acquired 03/25/2024 as awards. The excerpt also shows 9,136 shares sold on 04/15/2026 with an associated figure of $2,800,713.32.
JPMorgan Chase reported strong first-quarter 2026 results, with net income of $16.5 billion, up 13% from a year earlier, and diluted EPS of $5.94, up 17%. Total net revenue rose 10% to $49.8 billion, as net interest income grew 9% and noninterest revenue increased 11% on higher markets, asset management and investment banking fees.
Credit costs improved, with the provision for credit losses down 24% to $2.5 billion and stable net charge-offs of $2.3 billion. Return on common equity was 19% and return on tangible common equity 23%. The balance sheet remained large and liquid, with total assets of $4.9 trillion, deposits of $2.7 trillion and a standardized CET1 ratio of 14.3%. Management’s 2026 outlook calls for about $103 billion of net interest income and adjusted expenses near $105 billion, and highlights growth initiatives such as the Apple Card portfolio acquisition and a potential gain from tendered Visa B‑2 shares.
JPMorgan Chase & Co: Vanguard Capital Management reports beneficial ownership of 190,479,749 shares of Common Stock, equal to 7.06% of the class, as disclosed on a Schedule 13G covering 03/31/2026.
The filing states Vanguard has sole dispositive power for 190,479,749 shares and sole voting power for 25,201,016 shares. The report is signed by Vanguard's Head of Global Fund Administration on 04/30/2026.
JPMorgan Chase & Co. reported that its Board of Directors approved amendments to the company’s By-laws, effective April 21, 2026. The changes update the advancement provisions in Article IX so that any advancement of fees or expenses must comply with terms and conditions established by the corporation, which the corporation may amend or modify. The full amended By-laws, marked to show changes from the prior version, are provided as an exhibit.
JPMorgan Chase & Co. completed several large debt offerings. The bank closed public offerings of $500,000,000 Floating Rate Notes due 2030, $2,750,000,000 Fixed-to-Floating Rate Notes due 2030, $3,000,000,000 Fixed-to-Floating Rate Notes due 2032, and $3,750,000,000 Fixed-to-Floating Rate Notes due 2037.
The Notes were issued under an effective shelf registration statement on Form S-3. JPMorgan Chase filed a legal opinion from Simpson Thacher & Bartlett LLP as Exhibit 5.1, along with related consent and Inline XBRL cover page data.